Piotr Ponikowski

263.1k total citations · 30 hit papers
799 papers, 44.7k citations indexed

About

Piotr Ponikowski is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Piotr Ponikowski has authored 799 papers receiving a total of 44.7k indexed citations (citations by other indexed papers that have themselves been cited), including 591 papers in Cardiology and Cardiovascular Medicine, 112 papers in Hematology and 107 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Piotr Ponikowski's work include Heart Failure Treatment and Management (378 papers), Cardiovascular Function and Risk Factors (179 papers) and Erythropoietin and Anemia Treatment (106 papers). Piotr Ponikowski is often cited by papers focused on Heart Failure Treatment and Management (378 papers), Cardiovascular Function and Risk Factors (179 papers) and Erythropoietin and Anemia Treatment (106 papers). Piotr Ponikowski collaborates with scholars based in Poland, United States and United Kingdom. Piotr Ponikowski's co-authors include Stefan D. Anker, Gerasimos Filippatos, Adriaan A. Voors, Andrew J.S. Coats, Ewa A. Jankowska, Waldemar Banasiak, Marco Metra, Philip A. Poole‐Wilson, Stefan D. Anker and Dirk J. van Veldhuisen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Piotr Ponikowski

763 papers receiving 43.5k citations

Hit Papers

Ferric Carboxymaltose in ... 1997 2026 2006 2016 2009 2020 1997 2014 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
    2009 1.4k citations Stefan D. Anker, Josep Comín Colet et al. New England Journal of Medicine profile →
  2. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
    2020 1.2k citations Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine profile →
  3. Wasting as independent risk factor for mortality in chronic heart failure
    1997 1.1k citations Stefan D. Anker, Piotr Ponikowski et al. The Lancet profile →
  4. Heart Failure: Preventing Disease and Death Worldwide
    2014 936 citations Piotr Ponikowski, Stefan D. Anker et al. profile →
  5. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
    2006 901 citations Piotr Ponikowski, Luigi Tavazzi et al. profile →
  6. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
    2014 821 citations Piotr Ponikowski, Dirk J. van Veldhuisen et al. profile →
  7. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    2020 781 citations Piotr Ponikowski, Adriaan A. Voors et al. New England Journal of Medicine profile →
  8. Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia
    1997 641 citations Stefan D. Anker, Piotr Ponikowski et al. Circulation profile →
  9. EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
    2013 588 citations Aldo P. Maggioni, Ulf Dahlström et al. European Journal of Heart Failure profile →
  10. Iron deficiency in chronic heart failure: An international pooled analysis
    2013 534 citations Josep Comín‐Colet, Adriaan A. Voors et al. profile →
  11. Exercise Training in Heart Failure: From Theory to Practice. A Consensus Document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation
    2011 486 citations Kenneth Dickstein, Tiny Jaarsma et al. European Journal of Heart Failure profile →
  12. Iron deficiency: an ominous sign in patients with systolic chronic heart failure
    2010 481 citations Ewa A. Jankowska, John J.V. McMurray et al. profile →
  13. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
    2013 447 citations Lars Køber, Piotr Ponikowski et al. profile →
  14. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
    2022 439 citations Alexandre Mebazaa, Beth A. Davison et al. The Lancet profile →
  15. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
    2016 337 citations Barry Greenberg, G. Michael Felker et al. The Lancet profile →
  16. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
    2017 302 citations Dirk J. van Veldhuisen, Piotr Ponikowski et al. Circulation profile →
  17. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
    2016 299 citations Gerasimos Filippatos, Stefan D. Anker et al. profile →
  18. Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis
    2017 291 citations Stefan D. Anker, Bridget‐Anne Kirwan et al. European Journal of Heart Failure profile →
  19. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
    2015 281 citations Gerasimos Filippatos, Aldo P. Maggioni et al. profile →
  20. A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)
    2019 259 citations John J.V. McMurray, David L. DeMets et al. European Journal of Heart Failure profile →
  21. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
    2020 243 citations Stefan D. Anker, Javed Butler et al. Circulation profile →
  22. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
    2020 184 citations Christopher M. O’Connor, Piotr Ponikowski et al. profile →
  23. Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
    2021 140 citations Silvio E. Inzucchi, Lars Køber et al. profile →
  24. Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction
    2021 130 citations Subodh Verma, Silvio E. Inzucchi et al. profile →
  25. Ferric Carboxymaltose in Heart Failure with Iron Deficiency
    2023 120 citations Robert J. Mentz, Javed Butler et al. New England Journal of Medicine profile →
  26. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
    2022 119 citations Jan Biegus, Adriaan A. Voors et al. profile →
  27. Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions
    2023 115 citations Lars H. Lund, Piotr Ponikowski et al. Journal of the American College of Cardiology profile →
  28. Iron deficiency and cardiovascular disease
    2022 108 citations Gianluigi Savarese, Javed Butler et al. profile →
  29. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis
    2023 67 citations Piotr Ponikowski, Robert J. Mentz et al. profile →
  30. 2024 Update in Heart Failure
    2024 52 citations Jan Biegus, Piotr Ponikowski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Ponikowski Poland 109 30.2k 6.9k 6.8k 6.4k 4.7k 799 44.7k
Gerasimos Filippatos Greece 99 30.8k 1.0× 3.4k 0.5× 7.5k 1.1× 7.9k 1.2× 6.3k 1.3× 625 43.8k
Dirk J. van Veldhuisen Netherlands 126 43.8k 1.5× 5.5k 0.8× 7.7k 1.1× 5.6k 0.9× 7.9k 1.7× 857 60.8k
Stefan D. Anker Germany 117 27.4k 0.9× 5.4k 0.8× 7.5k 1.1× 8.9k 1.4× 7.4k 1.6× 734 56.7k
Adriaan A. Voors Netherlands 100 28.3k 0.9× 2.7k 0.4× 7.2k 1.0× 5.7k 0.9× 5.6k 1.2× 688 41.4k
Philip A. Poole‐Wilson United Kingdom 70 18.0k 0.6× 2.3k 0.3× 3.1k 0.5× 3.2k 0.5× 3.1k 0.7× 202 26.4k
Scott D. Solomon United States 140 64.9k 2.2× 2.9k 0.4× 14.1k 2.1× 13.2k 2.1× 13.5k 2.9× 1.2k 93.2k
Karl Swedberg Sweden 111 53.2k 1.8× 1.2k 0.2× 8.7k 1.3× 9.6k 1.5× 5.9k 1.3× 507 64.0k
Javed Butler United States 91 29.1k 1.0× 995 0.1× 6.2k 0.9× 8.1k 1.3× 6.4k 1.4× 825 42.1k
Andrew J.S. Coats United Kingdom 106 40.4k 1.3× 1.1k 0.2× 6.4k 0.9× 4.3k 0.7× 7.2k 1.6× 660 54.4k
Luigi Tavazzi Italy 105 39.9k 1.3× 1.4k 0.2× 4.7k 0.7× 2.3k 0.4× 7.2k 1.5× 579 47.5k

Countries citing papers authored by Piotr Ponikowski

Since Specialization
Citations

This map shows the geographic impact of Piotr Ponikowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Ponikowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Ponikowski more than expected).

Fields of papers citing papers by Piotr Ponikowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Ponikowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Ponikowski. The network helps show where Piotr Ponikowski may publish in the future.

Co-authorship network of co-authors of Piotr Ponikowski

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Ponikowski. A scholar is included among the top collaborators of Piotr Ponikowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Ponikowski. Piotr Ponikowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niewiński, Piotr, Stanisław Tubek, Krystian Josiak, Krzysztof Nowak, & Piotr Ponikowski. (2025). Cardiac parasympathetic denervation reduces hypoxic tachycardia, baroreflex sensitivity and heart rate variability in humans. Scientific Reports. 15(1). 6633–6633. 1 indexed citations
2.
Metra, Marco, Daniela Tomasoni, Marianna Adamo, et al.. (2025). Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions. Circulation. 151(18). 1342–1363. 2 indexed citations
3.
Ferreira, João Pedro, Jon Blatchford, John R. Teerlink, et al.. (2023). Mineralocorticoid Receptor Antagonist Use and the Effects of Empagliflozin on Clinical Outcomes in Patients Admitted for Acute Heart Failure: Findings from EMPULSE. European Journal of Heart Failure. 25(10). 1797–1805. 6 indexed citations
4.
Berka, Petr, et al.. (2022). Machine Learning Approach to Understand Worsening Renal Function in Acute Heart Failure. Biomolecules. 12(11). 1616–1616. 4 indexed citations
5.
Emmens, Johanna E., Martin H. de Borst, Eva M. Boorsma, et al.. (2022). Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure. Clinical Journal of the American Society of Nephrology. 17(2). 228–239. 9 indexed citations
6.
Mebazaa, Alexandre, Beth A. Davison, Ovidiu Chioncel, et al.. (2022). Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. The Lancet. 400(10367). 1938–1952. 439 indexed citations breakdown →
7.
Bhatt, Deepak L., Michael Szarek, Philippe Gabríel Steg, et al.. (2020). Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. New England Journal of Medicine. 384(2). 117–128. 1204 indexed citations breakdown →
8.
Beldhuis, Iris E., Koen W. Streng, Peter van der Meer, et al.. (2019). Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. Journal of Cardiac Failure. 25(11). 866–874. 15 indexed citations
9.
McMurray, John J.V., David L. DeMets, Silvio E. Inzucchi, et al.. (2019). A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF). European Journal of Heart Failure. 21(5). 665–675. 259 indexed citations breakdown →
10.
Streng, Koen W., Jan F. Nauta, Hans L. Hillege, et al.. (2018). Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology. 271. 132–139. 147 indexed citations
11.
Tromp, Jasper, B. Daan Westenbrink, Wouter Ouwerkerk, et al.. (2018). Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. Journal of the American College of Cardiology. 72(10). 1081–1090. 208 indexed citations
12.
Ferreira, João Pedro, Patrick Rossignol, Biniyam G. Demissei, et al.. (2017). Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart. 104(7). 606–613. 14 indexed citations
13.
Niewiński, Piotr, Stanisław Tubek, Waldemar Banasiak, Julian F. R. Paton, & Piotr Ponikowski. (2014). Consequences of peripheral chemoreflex inhibition with low‐dose dopamine in humans. The Journal of Physiology. 592(6). 1295–1308. 33 indexed citations
14.
Gutzwiller, F, Matthias Schwenkglenks, Patricia R. Blank, et al.. (2012). Health Economic Assessment of Ferric Carboxymaltose in Patients with Iron Deficiency and Chronic Heart Failure Based on the FAIR-HF Trial: An Analysis for the UK. European Journal of Heart Failure. 14(7). 782–790. 48 indexed citations
15.
Voors, Adriaan A., Beth A. Davison, G. Michael Felker, et al.. (2011). Early Drop in Systolic Blood Pressure and Worsening Renal Function in Acute Heart Failure: Renal Results of Pre-RELAX-AHF. European Journal of Heart Failure. 13(9). 961–967. 90 indexed citations
16.
Maggioni, Aldo P., Ulf Dahlström, Gerasimos Filippatos, et al.. (2010). EUR Observational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure. 12(10). 1076–1084. 295 indexed citations
17.
Anker, Stefan D., Josep Comín Colet, Gerasimos Filippatos, et al.. (2009). Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. New England Journal of Medicine. 361(25). 2436–2448. 1401 indexed citations breakdown →
18.
Metra, Marco, Piotr Ponikowski, Kenneth Dickstein, et al.. (2007). Advanced Chronic Heart Failure: A Position Statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 9(6-7). 684–694. 269 indexed citations
19.
Zaczyńska, Ewa, Anna Czarny, Ewa A. Jankowska, Maciej Sobczyński, & Piotr Ponikowski. (2007). Clinical immunology NF-κB expression in mononuclear cells from patients with chronic heart failure observed in endotoxin tolerance. Central European Journal of Immunology. 32(4). 206–211. 1 indexed citations
20.
Pinna, Gian Domenico, Roberto Maestri, Andrea Mortara, et al.. (2006). Nocturnal periodic breathing is an independent predictor of cardiac death and multiple hospital admissions in Heart failure. Oxford University Research Archive (ORA) (University of Oxford). 33. 837–840. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerasimos Filippatos Breakdown of academic impact, for papers by Dirk J. van Veldhuisen Breakdown of academic impact, for papers by Stefan D. Anker Breakdown of academic impact, for papers by Adriaan A. Voors Breakdown of academic impact, for papers by Philip A. Poole‐Wilson Breakdown of academic impact, for papers by Scott D. Solomon Breakdown of academic impact, for papers by Karl Swedberg Breakdown of academic impact, for papers by Javed Butler Breakdown of academic impact, for papers by Andrew J.S. Coats Breakdown of academic impact, for papers by Luigi Tavazzi
Rankless by CCL
2026